Clinical Trial Update: Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating vadadustat for correction of anemia in non-dialysis-dependent chronic kidney disease has completed, with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• Vadadustat (vadadustat)

Snippet

Sponsor: Akebia Therapeutics | Conditions: Anemia, Non-Dialysis-Dependent Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2022-06-27